These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25294655)

  • 1. A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia.
    VanderWeide LA; Smith SM; Trinkley KE
    J Clin Pharm Ther; 2015 Feb; 40(1):1-6. PubMed ID: 25294655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
    Häuser W; Urrútia G; Tort S; Uçeyler N; Walitt B
    Cochrane Database Syst Rev; 2013 Jan; (1):CD010292. PubMed ID: 23440848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.
    Park P; Caballero J; Omidian H
    Ann Pharmacother; 2014 Jan; 48(1):86-92. PubMed ID: 24259607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
    Dell'Osso B; Nestadt G; Allen A; Hollander E
    J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine treatment of fibromyalgia.
    Sayar K; Aksu G; Ak I; Tosun M
    Ann Pharmacother; 2003 Nov; 37(11):1561-5. PubMed ID: 14565792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of venlafaxine in other psychiatric disorders.
    Ninan PT
    Depress Anxiety; 2000; 12 Suppl 1():90-4. PubMed ID: 11098421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.
    Vis PM; van Baardewijk M; Einarson TR
    Ann Pharmacother; 2005 Nov; 39(11):1798-807. PubMed ID: 16189284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine and fibromyalgia.
    Dryson E
    N Z Med J; 2000 Mar; 113(1105):87. PubMed ID: 10855592
    [No Abstract]   [Full Text] [Related]  

  • 12. Milnacipran for pain in fibromyalgia in adults.
    Cording M; Derry S; Phillips T; Moore RA; Wiffen PJ
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008244. PubMed ID: 26482422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
    Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
    JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
    Davidson J; Baldwin D; Stein DJ; Kuper E; Benattia I; Ahmed S; Pedersen R; Musgnung J
    Arch Gen Psychiatry; 2006 Oct; 63(10):1158-65. PubMed ID: 17015818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
    Stahl SM; Grady MM; Moret C; Briley M
    CNS Spectr; 2005 Sep; 10(9):732-47. PubMed ID: 16142213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
    Mallick R; Chen J; Entsuah AR; Schatzberg AF
    J Clin Psychiatry; 2003 Mar; 64(3):321-30. PubMed ID: 12716275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials.
    Courtney DB
    Can J Psychiatry; 2004 Aug; 49(8):557-63. PubMed ID: 15453105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.
    Rynn MA; Riddle MA; Yeung PP; Kunz NR
    Am J Psychiatry; 2007 Feb; 164(2):290-300. PubMed ID: 17267793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine for neuropathic pain in adults.
    Gallagher HC; Gallagher RM; Butler M; Buggy DJ; Henman MC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011091. PubMed ID: 26298465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.